Project description
Disease detection with next-gen proteomics
Detecting diseases early and understanding their mechanisms rely on identifying key proteins in blood. However, current proteomics methods struggle to detect low-abundance proteins that are crucial for diagnosis and treatment. The EU-funded NEXT-UP project is developing an advanced mass spectrometry (MS)-based proteomics platform that doubles chromatographic resolution and boosts MS sensitivity by three orders of magnitude. The innovation includes next-generation monolithic capillary columns with a nanostructured flow-through pore system and an ultra-low-flow microfluidic modulator chip for high-precision sample transfer. Supported by the Marie Skłodowska-Curie Actions programme, the NEXT-UP project aims to revolutionise early disease detection and personalised medicine. Specifically, it will bridge cutting-edge technology with clinical research to transform healthcare.
Objective
NEXT-UP involves the development of a cutting-edge proteomics analytical platform for untargeted mass spectrometry (MS) based proteome profiling doubling the chromatographic resolving power and delivering an unprecedented three-order magnitude increase in MS detection sensitivity. Key technological advancements include the development of a new generation of precision-engineered monolithic capillary columns, designed with a nanostructured flow-through pore system, which is compatible with ultra-low-flow (<20 nL/min) operation. In addition, an innovative microfluidic modulator chip will be designed and constructed to enable sample transfer in two-dimensional liquid chromatographic (2D-LC) separations on a nanoflow scale. Proof-of-Concept involves the comprehensive identification of plasma protein signatures in serum. Consequently, the NEXT-UP initiative aims to unravel plasma proteomics by revealing high-impact, low-abundance proteins, with the goal of advancing early disease detection, uncover disease mechanisms, and revolutionizing personalized treatments. The project will be conducted at the VUB having unique expertise in biocolumn and chip design/prototyping and nanoLC-MS omics in close collaboration with HZI providing relevant samples and knowhow in clinical (plasma-) proteomics, bioinformatics/statistics matching the demands in translational research and systems level approaches.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2024-PF-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1050 BRUSSEL
Belgium
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.